Cargando…

Durable Near-Complete Response to Olaparib Plus Temozolomide and Radiation in a Patient With ATM-Mutated Glioblastoma and MSH6-Deficient Lynch Syndrome

Detalles Bibliográficos
Autores principales: File, Danielle M., Morgan, Katherine P., Khagi, Simon
Formato: Online Artículo Texto
Lenguaje:English
Publicado: American Society of Clinical Oncology 2020
Materias:
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7446372/
https://www.ncbi.nlm.nih.gov/pubmed/32923878
http://dx.doi.org/10.1200/PO.20.00112
_version_ 1783574143105499136
author File, Danielle M.
Morgan, Katherine P.
Khagi, Simon
author_facet File, Danielle M.
Morgan, Katherine P.
Khagi, Simon
author_sort File, Danielle M.
collection PubMed
description
format Online
Article
Text
id pubmed-7446372
institution National Center for Biotechnology Information
language English
publishDate 2020
publisher American Society of Clinical Oncology
record_format MEDLINE/PubMed
spelling pubmed-74463722020-09-30 Durable Near-Complete Response to Olaparib Plus Temozolomide and Radiation in a Patient With ATM-Mutated Glioblastoma and MSH6-Deficient Lynch Syndrome File, Danielle M. Morgan, Katherine P. Khagi, Simon JCO Precis Oncol Molecular Tumor Board American Society of Clinical Oncology 2020-07-23 /pmc/articles/PMC7446372/ /pubmed/32923878 http://dx.doi.org/10.1200/PO.20.00112 Text en © 2020 by American Society of Clinical Oncology https://creativecommons.org/licenses/by-nc-nd/4.0/ Creative Commons Attribution Non-Commercial No Derivatives 4.0 License: https://creativecommons.org/licenses/by-nc-nd/4.0/
spellingShingle Molecular Tumor Board
File, Danielle M.
Morgan, Katherine P.
Khagi, Simon
Durable Near-Complete Response to Olaparib Plus Temozolomide and Radiation in a Patient With ATM-Mutated Glioblastoma and MSH6-Deficient Lynch Syndrome
title Durable Near-Complete Response to Olaparib Plus Temozolomide and Radiation in a Patient With ATM-Mutated Glioblastoma and MSH6-Deficient Lynch Syndrome
title_full Durable Near-Complete Response to Olaparib Plus Temozolomide and Radiation in a Patient With ATM-Mutated Glioblastoma and MSH6-Deficient Lynch Syndrome
title_fullStr Durable Near-Complete Response to Olaparib Plus Temozolomide and Radiation in a Patient With ATM-Mutated Glioblastoma and MSH6-Deficient Lynch Syndrome
title_full_unstemmed Durable Near-Complete Response to Olaparib Plus Temozolomide and Radiation in a Patient With ATM-Mutated Glioblastoma and MSH6-Deficient Lynch Syndrome
title_short Durable Near-Complete Response to Olaparib Plus Temozolomide and Radiation in a Patient With ATM-Mutated Glioblastoma and MSH6-Deficient Lynch Syndrome
title_sort durable near-complete response to olaparib plus temozolomide and radiation in a patient with atm-mutated glioblastoma and msh6-deficient lynch syndrome
topic Molecular Tumor Board
url https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7446372/
https://www.ncbi.nlm.nih.gov/pubmed/32923878
http://dx.doi.org/10.1200/PO.20.00112
work_keys_str_mv AT filedaniellem durablenearcompleteresponsetoolaparibplustemozolomideandradiationinapatientwithatmmutatedglioblastomaandmsh6deficientlynchsyndrome
AT morgankatherinep durablenearcompleteresponsetoolaparibplustemozolomideandradiationinapatientwithatmmutatedglioblastomaandmsh6deficientlynchsyndrome
AT khagisimon durablenearcompleteresponsetoolaparibplustemozolomideandradiationinapatientwithatmmutatedglioblastomaandmsh6deficientlynchsyndrome